A Tokyo-based manufacturer is ramping up production of glass vials needed worldwide for COVID-19 vaccination programs. Murase Glass Co., a company that processes needles and vials that are ...

Mon, 06 Jan 2025 06:23:05 GMT MILAN (Reuters) - Italian vaccine vial maker Stevanato on Tuesday slightly improved its guidance on full-year results after reporting a 37% increase in third quarter ...

Scientists and vaccine-makers broke speed records developing COVID-19 vaccines that have saved tens of millions of lives worldwide – and were the critical step to getting life back to normal.

Once there, he received 10 vials of antivenom, however, the swelling on his shin continued to increase. At first, the pain was so bad that he didn’t think it was the result of a snake bite.

Vaccines protect babies and children from potentially life-threatening diseases. Widespread childhood vaccination has reduced or eliminated deadly diseases like polio and smallpox. Vaccines currently ...

Vaccines and aborted fetal tissue are linked in some cases. That's because certain vaccines, such as a type of rabies vaccine, are made by cultivating the virus in fetal cells. The Janssen COVID-19 ...

Today it is driving efforts to create a new generation of therapies known as “cancer vaccines” that aim to train the immune system to recognise tumours and fight their spread. Trials are now ...

System to auto-detect new variants will inform better response to future infectious disease outbreaks Date: January 1, 2025 Source: University of Cambridge Summary: Researchers have come up with a ...

Wen on Sunday also urged the Biden administration to approve the H5N1 vaccine, which is already developed and contracted with manufacturers to make almost 5 million doses but awaits FDA ...

Can you get a vaccine to prevent all cancers? Reports in Russia’s state-run news agency claimed this week that Russian scientists have developed an mRNA vaccine that has shown the ability to suppress ...

They also could not put up signs at the department’s clinics that COVID, flu or mpox vaccines were available on site. And we conclude, as is our custom, in the great state of Oklahoma ...

BioNTech has agreed to pay $1.26 billion across two separate settlements with the National Institutes of Health and the University of Pennsylvania tied to royalties for its Covid-19 vaccine.